Alembic Pharmaceuticals gains USFDA final approval for Carbamazepine Extended-Release Tablets EP News Bureau Jul 28, 2025 Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug and also for treating pain associated with…
